RISK Medical Solutions - RetinaRisk Information

The clinically validated RetinaRisk algorithm empowers people living with diabetes and leads to more streamlined and personalized healthcare. The RetinaRisk app empowers the global diabetic population of 463 million to calculate and better understand their individualized risk of developing sight-threatening eye disease that could lead to blindness. With early detection and timely treatment vision loss can be prevented in 95% of cases. The RetinaRisk API solution serves healthcare professionals as a decision support tool to enhance the clinical safety of patients by identifying high-risk patients and can help hospitals and national healthcare systems to streamline diabetic retinopathy eye screening and make it more efficient and cost-effective. For more information check out our website: https://www.retinarisk.com/ RetinaRisk was developed by Prof. Einar Stefansson, Professor at the Department of Ophthalmology, University of Iceland and Dr. Arna Gudmundsdottir, Endocrinologist at the National Hospital Reykjavik, who have over 30 years’ experience in screening for diabetic retinopathy and treating diabetes. Our algorithm is based on extensive international research and has been clinically validated in over 25.000 diabetic patients in five countries and found to be extremely robust (Aspelund et al., 2011; van der Heijden et al. 2014; Soto‐Pedre et al. 2015; Lund et al 2016; Schreur et al 2019). https://www.retinarisk.com/research/ RetinaRisk is focused on wellness, prevention and personalization through digital engagement and predictive analytics. We’re witnessing the rise of digital health and fundamental changes in healthcare with patients becoming more knowledgeable and active participants in their wellness journey. RetinaRisk offers a truly personalized approach leading to the right patient receiving the right treatment at the right time.